Similarly, the transwell chamber assay corroborated these findings, demonstrating that overexpression of SLC25A39 markedly increased CRC cell migration, while knockdown of SLC25A39 had the opposite effect (Fig. 3C). The gene discussed is SLC25A39; the disease is colorectal carcinoma.